| Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 9.8241 | 10.3500 | 11.4700 | 8.7630 | 11.4700 | 18.74% |
| 2024 | 16.6468 | 15.8240 | 23.2300 | 9.2920 | 9.6600 | -38.24% |
| 2023 | 82.2696 | 120.2900 | 162.1500 | 15.6400 | 15.6400 | -86.74% |
| 2022 | 157.4804 | 310.9600 | 310.9600 | 74.9800 | 117.9900 | -60.36% |
| 2021 | 567.9576 | 911.9500 | 1046.5000 | 297.6200 | 297.6200 | -66.34% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| $0.000B | $0.000B | ||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OncoCyte (IMDX) | United States | $0.090B | 0.00 |
| GlycoMimetics (CBIO) | United States | $0.009B | 0.00 |